학술논문

Assessment of No Evidence of Disease Activity (NEDA-3) in alemtuzumab-treated patients with aggressive multiple sclerosis who failed multiple disease-modifying drugs
Document Type
Journal
Source
MULTIPLE SCLEROSIS JOURNAL; SEP 2016, 22 p284-p285, 2p. Supplement: 3
Subject
Language
English
ISSN
14770970